Renal Replacement Therapy Access, Utilization, and Maternal Mortality in Pregnancy- Related Acute Kidney Injury in Africa: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis of 14 studies from nine African countries reveals that while renal replacement therapy utilization for pregnancy-related acute kidney injury is significantly lower in unselected populations than in dialysis-selected cohorts, maternal and perinatal mortality rates remain critically high, underscoring the urgent need for improved early detection, referral pathways, and equitable expansion of dialysis capacity.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a woman's kidneys suddenly stop working during pregnancy or shortly after birth, the situation is a medical emergency known as pregnancy-related acute kidney injury. This condition, which can be triggered by severe high blood pressure, heavy bleeding, or infection, cuts off the body's ability to filter waste and balance fluids. In wealthier nations, doctors have long relied on a life-saving machine called renal replacement therapy to do the kidneys' work temporarily, allowing the body time to heal. This treatment, which includes dialysis, has become a standard part of care for the most severe cases. However, in many parts of Africa, the path to this treatment is often blocked by distance, cost, or a simple lack of machines and specialists. The question of how many women actually reach this life-saving care, and whether receiving it changes their chances of survival, has remained difficult to answer because the data has been scattered and incomplete.
A new comprehensive review brings these scattered pieces together to paint a clearer picture of the crisis across the African continent. Researchers gathered and analyzed data from fourteen different studies involving nearly 1,100 women from nine countries, spanning regions from Egypt in the north to Kenya and Tanzania in the east, and Nigeria in the west. Their goal was to move beyond isolated hospital reports and understand the real-world landscape: how many women with this condition actually receive dialysis, and what happens to those who do versus those who do not. The team carefully sifted through decades of medical records, looking specifically at whether the studies included all women with the condition or only those who had already been selected for treatment, a distinction that proved crucial to their findings.
The most striking discovery from this analysis is that the apparent availability of dialysis is often an illusion created by how the data is collected. When the researchers looked at groups of women that included everyone diagnosed with the condition, regardless of whether they got treatment, they found that only about nine out of every hundred women actually received renal replacement therapy. This number is shockingly low compared to earlier reports that suggested over half of all patients were treated. Those higher numbers came from studies that only looked at women who had already been sent to dialysis centers, effectively ignoring the many women who never made it that far. The review suggests that for the vast majority of women with this condition across Africa, the life-saving machine remains out of reach.
Despite the low rate of treatment, the outcomes for the women who did receive care were mixed, revealing a complex reality of survival and loss. The overall rate of death among women with this condition was about 13 percent, but this number varied wildly depending on where the study took place. In some regions, particularly in East Africa, the death rate was lower, while in West Africa, it was significantly higher. The researchers noted that women who received dialysis often had much more severe illness to begin with, requiring intensive care and breathing support, which makes it difficult to say if the treatment itself caused the higher death rates seen in some specific groups. Instead, the high mortality likely reflects the extreme severity of the underlying conditions, such as severe pre-eclampsia or sepsis, that led to the kidney failure in the first place.
Even with these grim statistics, there is a glimmer of hope in the body's ability to recover. Among the women who survived the acute phase of the illness, about two-thirds eventually regained normal kidney function. This suggests that pregnancy-related kidney injury is often reversible if the woman can survive the initial crisis and receive appropriate care. However, the cost of this survival is high for the unborn or newborn children. The review found that nearly 40 percent of pregnancies ended in the loss of the baby, a tragedy that underscores how the health of the mother and child are inextricably linked. The leading causes of these injuries were consistent across the continent: severe high blood pressure disorders, heavy bleeding during or after birth, and infections.
The barriers preventing women from getting the care they need are not just medical but deeply structural. The review identified a chain of obstacles that often breaks the chain of survival: a lack of money to pay for treatment, long delays in getting referred from local clinics to major hospitals, and a shortage of doctors trained in kidney care. In many cases, a woman might arrive at a hospital that has a dialysis machine, but if that hospital lacks the intensive care unit needed to support her while she is on the machine, the treatment cannot be given. The researchers emphasize that simply building more dialysis centers is not enough; the solution requires a coordinated system that includes better early detection of pregnancy complications, faster referral pathways, and the integration of kidney care with critical care services. Without addressing these systemic gaps, the potential for this life-saving treatment to save lives will remain largely unrealized for the women who need it most.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.